NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor
Currently approved for patients eight and older, Tzield could now be used to delay the onset of stage 3 type 1 diabetes (T1D) in children diagnosed with stage 2 T1D
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
All pending litigation between Biocon Biologics, Regeneron, and Bayer will be dismissed
The FDA aims to make a decision by April 8, 2026
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Renalyx will continue operating as an independent unit within the group
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Subscribe To Our Newsletter & Stay Updated
